Scientific Sessions draws big-name speakers

eP3_Story1_smallREVScientific Sessions 2016 will provide attendees with an unprecedented opportunity to meet and network with big-name presenters in the world of cardiovascular discovery and care Nov. 12-16 in New Orleans.

One great opportunity to meet some of the titans of our industry will be at the Frontiers in Science: Stem Cells Summit on Tuesday, Nov. 15. This new, cutting-edge program will feature 40 interdisciplinary speakers who will discuss the latest developments in stem cell research as it pertains to all facets of cardiovascular science and clinical care. The Program Chair for this one-of-a-kind program, Eduardo Marban, MD, PhD, from Cedars-Sinai Institute, Los Angeles, will welcome legendary faculty members, such as Victor Dzau, MD, Stefanie Dimmeler, MD, PhD, FAHA, and Eugene Braunwald, MD, FAHA. Sessions include: Stem Cell Biology, Paracrine Mediators of Stem Cell Bioactivity, Integrative Models and Translation and Clinical Trials. Just as the Stem Cells Summit brings the latest breakthroughs in lightning-speed talks, so do three other noteworthy Frontiers in Science summits: the Arrhythmia Research Summit, Thrombosis Summit and Vascular Disease Summit.

FDA Commissioner Robert M. Califf, MD, is just one of multiple big names that will speak at the highly anticipated Precision Medicine Summit on Monday, Nov. 14. Topics include diagnosing disease with genomic technology, the FDA’s perspective on precision therapeutics for cardiovascular disease and personalizing cardiovascular surgery.

With the 2016 introduction of Main Events, the AHA is giving greater focus to talks with distinguished speakers.

Main Event 1

  • Precision Medicine 2016
  • What Is the Role of PCSK9 Inhibitors in CV Prevention?
  • Acute Pulmonary Embolism in 2016: The Challenge of Rapidly Shifting Paradigms
  • Life’s Sort of Simple 7: Implementing Ideal CV Health Through the Lifespan
  • New Approaches to Repair The Damaged Cardiovascular System
  • Changing Landscape of Acute Coronary Syndrome Care
  • Many others

Main Event 2

  • Atrial Fibrillation — Innovating to Improve Outcomes
  • From Precision to Population: Optimizing Outcomes in HF
  • Frontiers in Heart Valve Disease
  • Maximizing PAD Outcomes in 2016
  • Cardiac Regeneration — Where Are We Now?
  • Dilemmas at the Forefront of Stable Ischemic Heart Disease Management
  • Many others

Expand your learning by connecting with lauded researchers involved in the Late-Breaking Clinical Trials during the Nov. 13 and 14 Meet the Trialists sessions. Select researchers will provide answers and insights about their studies during these informal sessions. Located in the Science & Technology Hall, these 45-minute sessions also give you the opportunity to address trial methods and hot issues.